Insider Transactions in Q4 2025 at Pluristem Therapeutics Inc (PSTI)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2025
|
Alexandre Weinstein Manieu Director |
BUY
Grant, award, or other acquisition
|
Indirect |
625,000
+50.0%
|
$1,250,000
$2.0 P/Share
|
|
Dec 04
2025
|
Zami Aberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
346
+0.24%
|
-
|
|
Dec 04
2025
|
Maital Shemesh Rasmussen Director |
BUY
Grant, award, or other acquisition
|
Direct |
699
+3.52%
|
-
|
|
Dec 04
2025
|
Liat Zalts Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,660
+3.8%
|
-
|
|
Dec 04
2025
|
Rami Avraham Levi Director |
BUY
Grant, award, or other acquisition
|
Direct |
653
+3.33%
|
-
|
|
Dec 04
2025
|
Yaky Yanay Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,588
+1.31%
|
-
|
|
Dec 04
2025
|
Eitan Ajchenbaum Director |
BUY
Grant, award, or other acquisition
|
Direct |
668
+5.13%
|
-
|
|
Dec 04
2025
|
Alexandre Weinstein Manieu Director |
BUY
Grant, award, or other acquisition
|
Direct |
519
+4.6%
|
-
|
|
Nov 12
2025
|
Eitan Ajchenbaum Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,685
+50.0%
|
-
|
|
Oct 29
2025
|
Alexandre Weinstein Manieu Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,002,169
+34.14%
|
-
|
|
Oct 15
2025
|
Yaky Yanay Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,050
+7.36%
|
-
|